A company started by a student who dropped out of the University of Utah School of Medicine to find cures for rare diseases has been awarded a $1.46 million federal grant.
The National Center for Advancing Translational Sciences (NCATS) will give Recursion Pharmaceuticals of Salt Lake City the grant over two years. NCATS is part of the National Institutes of Health.
The news came as advocates worldwide prepared to observe Rare Disease Day on Saturday as part of a campaign to raise awareness of the need for cures. Utah families attended a symposium on the subject at the U.
Chris Gibson, who finished his doctorate but left medical school to launch Recursion in late 2013, said the grant will help the company expand its work, which is essentially finding ways to repurpose drugs.